<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
 
 <title>BGI Cancer Research</title>
 <link href="http://username.github.io//" rel="self"/>
 <link href="http://username.github.io/"/>
 <updated>2014-05-03T18:24:52+08:00</updated>
 <id>http://username.github.io/</id>
 <author>
   <name>bigcr</name>
   <email>bigcr@email.test</email>
 </author>

 
 <entry>
   <title>Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing's Syndrome</title>
   <link href="http://username.github.io//2014/04/03/Activatin-Hotspot-L205R-Mutation-in-PRKACA-and-Adrenal-Cushing-Syndrome"/>
   <updated>2014-04-03T00:00:00+08:00</updated>
   <id>http://username.github.io//2014/04/03/Activatin-Hotspot-L205R-Mutation-in-PRKACA-and-Adrenal-Cushing-Syndrome</id>
   <content type="html">&lt;p&gt;Science DOI: 10.1126/science.1249480&lt;/p&gt;

&lt;h5 id='yanan_caominghui_hezhibo_gaoying_pengyanli_lilin_liweiwei_zhouxiangchun_lixu_zhongyiming_leitingwei_suhang_wangyiran_jianglin_yangwei_weixu_yangxiuli_jiangli_liujuan_hejunna_yeqing_weiyingrui_liweiqing_wangjun_wangguang_ning'&gt;Yanan Cao,Minghui He,Zhibo Gao,Ying Peng,Yanli Li,Lin Li,Weiwei Zhou,Xiangchun Li,Xu Zhong,Yiming Lei,Tingwei Su,Hang Wang,Yiran Jiang,Lin Yang,Wei Wei,Xu Yang,Xiuli Jiang,Li Liu,Juan He,Junna Ye,Qing Wei,Yingrui Li,Weiqing Wang,Jun Wang,Guang Ning,&lt;/h5&gt;

&lt;p&gt;Adrenal Cushing’s syndrome is caused by excess production of glucocorticoid from adrenocortical tumors and hyperplasias, which lead to metabolic disorders. We performed whole-exome sequencing of 49 blood-tumor pairs and RNA sequencing of 44 tumors from cortisol-producing adrenocortical adenomas (ACAs), ACTH-independent macronodular adrenocortical hyperplasia (AIMAH), and adrenocortical oncocytoma (ADO). We identified a hotspot in the PRKACA gene with a c.T617G/p.L205R mutation in 69.2% (27 out of 39) of ACAs and validated in 65.5% of total 87 ACAs. Our data revealed that the activating L205R mutation, which locates in the P+1 loop of PKA catalytic subunit, promoted PKA substrates phosphorylation and target genes expression. Moreover, we discovered recurrently mutated DOT1L in AIMAHs and CLASP2 in ADOs. Collectively, these data highlight potentially functional mutated genes in adrenal Cushing’s syndrome.&lt;/p&gt;
&lt;a href='http://www.sciencemag.org/content/early/2014/04/02/science.1249480.abstract'&gt; read more &lt;/a&gt;</content>
 </entry>
 
 <entry>
   <title>HuangXuanlin</title>
   <link href="http://username.github.io//Group2/2014/03/27/huangxuanlin"/>
   <updated>2014-03-27T00:00:00+08:00</updated>
   <id>http://username.github.io//Group2/2014/03/27/huangxuanlin</id>
   <content type="html">&lt;p&gt;HuangXuanlin received his bachelor’s degree of from Huazhong University of Science and Technology in 2010, joined BGI since 2012.7, and now, a core member of the cancer group at medical research department of BGI Tech.&lt;/p&gt;

&lt;p&gt;Xuanlin are now participating in genome research of esophageal squamous carcinoma, insulinomas and multiple endocrine neoplasia.&lt;/p&gt;

&lt;p&gt;Xuanlin has experience in detection methods of somatic CNAs and can skilled use AI， SVG and R. These tools are helpful for information analysis.&lt;/p&gt;

&lt;h4 id='main_publication'&gt;Main Publication:&lt;/h4&gt;
&lt;p&gt;
&lt;a href='/2013/12/10/Whole-exome-sequencing-of-insulinoma-reveals-recurrent-T372R-mutations-in-YY1'&gt;
Cao, Yanan, et al. &quot;Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.&quot; Nature communications 4 (2013).
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2014/03/16/Identification-of-genomic-alterations-in-oesophageal-squamous-cell-cancer/'&gt;Song, Yongmei, et al. &quot;Identification of genomic alterations in oesophageal squamous cell cancer.&quot; Nature (2014).
&lt;/a&gt;
&lt;/p&gt;</content>
 </entry>
 
 <entry>
   <title>WuQian</title>
   <link href="http://username.github.io//Group2/2014/03/21/wuqian"/>
   <updated>2014-03-21T00:00:00+08:00</updated>
   <id>http://username.github.io//Group2/2014/03/21/wuqian</id>
   <content type="html">&lt;img style='float:left;width:120px;height:180px' src='/assets/images/resume/wuqian.jpeg' /&gt;
&lt;p&gt;Wu Qian works on cancer genome analysis at BGI Shenzhen. Qian&amp;#8217;s work is mainly based on bioinformatics methods, including but not limited to the following aspects:&lt;/p&gt;

&lt;p&gt;Cancer project analysis;&lt;/p&gt;

&lt;p&gt;Algorithm on distinguishing &amp;#8220;driver&amp;#8221; and &amp;#8220;passenger&amp;#8221; mutations; CNV distinguishing;&lt;/p&gt;

&lt;p&gt;Project data submitting to public databases.&lt;/p&gt;

&lt;p&gt;Qian receive her B.Eng in Biomedical engineering in 2012 from Beijing Jiaotong University. After that, she got a master&amp;#8217;s degree in Biomedical engineering from the Chinese University of Hong Kong in 2013.&lt;/p&gt;</content>
 </entry>
 
 <entry>
   <title>YangXiao</title>
   <link href="http://username.github.io//Group2/2014/03/20/yangxiao"/>
   <updated>2014-03-20T00:00:00+08:00</updated>
   <id>http://username.github.io//Group2/2014/03/20/yangxiao</id>
   <content type="html">&lt;p&gt;Xiao Yang is the member of the team, he now develop the csap pipeline and Algorithm research.&lt;/p&gt;

&lt;p&gt;Yang received his B.A in automation in 2007 from the university of electronic science and technology of china&lt;/p&gt;</content>
 </entry>
 
 <entry>
   <title>HuangPeiDe</title>
   <link href="http://username.github.io//Group2/2014/03/19/huangpeide"/>
   <updated>2014-03-19T00:00:00+08:00</updated>
   <id>http://username.github.io//Group2/2014/03/19/huangpeide</id>
   <content type="html">&lt;img style='float:left;width:120px;height:180px' src='/assets/images/resume/huangpeide.jpg' /&gt;
&lt;p&gt;Name: Peide Huang Sex: Male &lt;br /&gt;Age: 29 &lt;br /&gt;Native place: Guangdong, China TEL：(086)151-1883-9736&lt;br /&gt;Email: huangpeide1984@gmail.com Contact address: 11th Building, Bei Shan Industrial Zone, Yantian District,Shenzhen,China&lt;/p&gt;

&lt;p&gt;I have a background of molecular and cellular biology from my school years. I have already worked in the field of cancer genomics for more than 3 years and accumulated rich researching experience in this field. I was engaged in several studies about the pathogenesis of different kinds of cancers (eg.TCCs and ccRCCs).&lt;/p&gt;

&lt;h4 id='education'&gt;Education&lt;/h4&gt;

&lt;h6 id='2013_now_phd_student'&gt;2013- Now Ph.D student&lt;/h6&gt;

&lt;p&gt;Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Danmark&lt;/p&gt;

&lt;h6 id='20072010_master_of_science_in_genetics_'&gt;2007-2010 Master of Science in Genetics 　&lt;/h6&gt;

&lt;p&gt;Jinan University, Guangdong, China Thesis: The Study on the Promotional Effect of rhBMP-2 on Metastasis of Breast Cancer&lt;/p&gt;

&lt;h6 id='20032007_bachelor_of_science_in_biotechnology'&gt;2003-2007 Bachelor of Science in Biotechnology　&lt;/h6&gt;

&lt;p&gt;Jinan University, Guangdong, China Thesis: The inhibitory effect of BMP-2 on the proliferation of breast cancer cell MDA-MB-231&lt;/p&gt;

&lt;h4 id='english_skills'&gt;English Skills&lt;/h4&gt;

&lt;p&gt;Have a good command of both spoken and written English.&lt;/p&gt;

&lt;h4 id='research_experience'&gt;Research Experience&lt;/h4&gt;

&lt;h5 id='pan_asiapacificcancer_research_department_bgi_tech'&gt;Pan Asia-Pacific Cancer Research Department, BGI Tech&lt;/h5&gt;

&lt;h6 id='project_leader_20122013'&gt;Project leader 2012-2013&lt;/h6&gt;

&lt;p&gt;Participated in the researches of Bladder cancers (TCCs) and adrenal adenomas (ccRCCs), which supported by the National High Technology Research and Development Program of China. Identified TERT promoter mutations as discrimination biomarkers for the origin of urogenital tumors. Publish researching articles on the Journals Nature Genetics and European Urology.&lt;/p&gt;

&lt;h5 id='department_of_science_and_technology_bgishenzhen'&gt;Department of Science and Technology, BGI.ShenZhen&lt;/h5&gt;

&lt;h6 id='assistant_researcher_2010_2011'&gt;Assistant Researcher 2010– 2011&lt;/h6&gt;

&lt;p&gt;Participated in the researches of clear cell renal carcinoma (ccRCC),which supported by National High Technology Research and Development Program of China. Publish researching articles on the Journals Nature Genetics. Developed methods for the validation of gene mutations, establish the Ofish platform for BGI.&lt;/p&gt;

&lt;h5 id='institute_of_bioengineeringjinan_university_guangdong_china'&gt;Institute of Bioengineering,Jinan University, Guangdong, China&lt;/h5&gt;

&lt;h6 id='master_student_2007__2010'&gt;Master Student, 2007 – 2010&lt;/h6&gt;

&lt;p&gt;Participated in the research about the effect of human recombinant protein BMP-2 (rhBMP-2) on breast cancer cells.&lt;/p&gt;

&lt;h4 id='publications'&gt;Publications&lt;/h4&gt;

&lt;p&gt;Wu S, Huang P, Li C, Huang Y, Li X, Wang Y, Chen C, Lv Z, Tang A, Sun X, Lu J, Li W, Zhou J, Gui Y, Zhou F, Wang D, Cai Z. Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study. Eur Urol. 2014 Feb; 65(2):274-7.&lt;/p&gt;
&lt;p&gt;
&lt;a href='/2013/10/13/Whole-genome-and-whole-exome-sequencing-of-bladder-cancer-identifies-frequent-alterations-in-genes-involved-in-sister-chromatid-cohesion-and-segregation'&gt;
Guo, Guangwu, et al. &quot;Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.&quot; Nature genetics 45.12 (2013): 1459-1463.
&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;Wang D, Huang P, Zhu B, Sun L, Huang Q, Wang J. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines. Mol Med Rep. 2012 Sep; 6 (3):591-6.&lt;/p&gt;

&lt;p&gt;Guo G, Gui Y, Gao S, Tang A, Hu X, Huang Y, Jia W, Li Z, He M, Sun L, Song P, Sun X, Zhao X, Yang S, Liang C, Wan S, Zhou F, Chen C, Zhu J, Li X, Jian M, Zhou L, Ye R, Huang P, Chen J, Jiang T, Liu X, Wang Y, Zou J, Jiang Z, Wu R, Wu S, Fan F, Zhang Z, Liu L, Yang R, Liu X, Wu H, Yin W, Zhao X, Liu Y, Peng H, Jiang B, Feng Q, Li C, Xie J, Lu J, Kristiansen K, Li Y, Zhang X, Li S, Wang J, Yang H, Cai Z, Wang J.Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nature Genet 2011;44:17-19&lt;/p&gt;

&lt;p&gt;Gui Y, Guo G, Huang Y, Hu X, Tang A, Gao S, Wu R, Chen C, Li X, Zhou L, He M, Li Z, Sun X, Jia W, Chen J, Yang S, Zhou F, Zhao X, Wu S, Ye R, Liang C, Liu Z, Huang P, Liu C, Jiang H, Wang Y, Zheng H, Sun L, Liu X, Jiang Z, Feng D, Chen J, Wu S, Zou J, Zhang Z, Yang R, Zhao J, Xu C, Yin W, Guan Z, Ye J, Zhang H, Li J, Kristiansen K, Nickerson ML, Theodorescu D, Li Y, Zhang X, Li S, Wang J, Yang H, Wang J, Cai Z.Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nature Genet 2011; 43:875-878&lt;/p&gt;

&lt;p&gt;Peide Huang, Feicheng Huang, Ju Wang.rhBMP2 enhance migration and invasion capacity of human breast cancer cells MCF-7.Chinese Journal of Pathophysiology.2010, 26(5):931-936&lt;/p&gt;</content>
 </entry>
 
 <entry>
   <title>LiLin</title>
   <link href="http://username.github.io//Group2/2014/03/18/lilin"/>
   <updated>2014-03-18T00:00:00+08:00</updated>
   <id>http://username.github.io//Group2/2014/03/18/lilin</id>
   <content type="html">&lt;img style='float:left;width:150px;height:180px' src='/assets/images/resume/lilin.jpeg' /&gt;
&lt;p&gt;Lin Li as a senior project manager at medical research department of BGI Tech. Lin’s current interest is to improve Cancer Sequencing Analysis Pipeline(CSAP) and develop Cancer Genome Interpretation Pipeline(CGIP). CSAP is a pipeline fully describing the genomic events in tumor and normal samples coming from a patient, including somatic variants detecting, purity estimating for NGS data. However, CGIP is a pipeline to analysis the characterization data based on cohort patients, including significant mutated genes(SMG), pathway enrichment, mutation spectrum analysis, mutation exclusive.&lt;/p&gt;

&lt;p&gt;Lin Li received his bachelor’s degree of Computer Science and Technology from Ocean University of China. As a senior bioinformatician, he and his team are now working on cancer research. He is a member of the ICGC Data Coordination and Management Working Group, a key member of the China Cancer Genome Consortium (CCGC), and takes charge of ICGC-China data submission. Now, he is mainly responsible for the bioinformatics analysis of esophageal cancer project from China.&lt;/p&gt;

&lt;p&gt;Lin has experience in detection methods of somatic SNVs, InDels, CNVs, SVs, Virus integration. These tools were important contents of CSAP.&lt;/p&gt;

&lt;h4 id='main_publication'&gt;Main Publication&lt;/h4&gt;
&lt;p&gt;
&lt;a href='/2013/12/10/Whole-exome-sequencing-of-insulinoma-reveals-recurrent-T372R-mutations-in-YY1'&gt;
Cao, Yanan, et al. &quot;Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1.&quot; Nature communications 4 (2013).
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2013/10/13/Whole-genome-and-whole-exome-sequencing-of-bladder-cancer-identifies-frequent-alterations-in-genes-involved-in-sister-chromatid-cohesion-and-segregation'&gt;
Guo, Guangwu, et al. &quot;Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.&quot; Nature genetics 45.12 (2013): 1459-1463.
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2013/06/17/Whole-genome-sequencing-identifies-recurrent-mutations-in-hepatocellular-carcinoma'&gt;
Kan, Zhengyan, et al. &quot;Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.&quot; Genome research 23.9 (2013): 1422-1433.
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2014/01/22/Identification-of-somatic-alterations-in-stage-I-lung-adenocarcinomas-by-next-generation-sequencing/'&gt;
Zhao, Yuda, et al. &quot;Identification of somatic alterations in stage I lung adenocarcinomas by next‐generation sequencing.&quot; Genes, Chromosomes and Cancer (2014).
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2014/03/16/Identification-of-genomic-alterations-in-oesophageal-squamous-cell-cancer/'&gt;
Song, Yongmei, et al. &quot;Identification of genomic alterations in oesophageal squamous cell cancer.&quot; Nature (2014).
&lt;/a&gt;
&lt;/p&gt;&lt;p&gt;
&lt;a href='/2014/04/03/Activatin-Hotspot-L205R-Mutation-in-PRKACA-and-Adrenal-Cushing-Syndrome'&gt;
Cao, Yanan, et al. &quot;Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing's Syndrome.&quot; Science (2014): 1249480.
&lt;/a&gt;
&lt;/p&gt;</content>
 </entry>
 
 <entry>
   <title>Identification of genomic alterations in oesophageal squamous cell cancer</title>
   <link href="http://username.github.io//2014/03/16/Identification-of-genomic-alterations-in-oesophageal-squamous-cell-cancer"/>
   <updated>2014-03-16T00:00:00+08:00</updated>
   <id>http://username.github.io//2014/03/16/Identification-of-genomic-alterations-in-oesophageal-squamous-cell-cancer</id>
   <content type="html">&lt;p&gt;doi:10.1038/nature13176&lt;/p&gt;

&lt;h5 id='yongmei_song_lin_li_yunwei_ou_zhibo_gao_enmin_li_xiangchun_li_weimin_zhang_jiaqian_wang_liyan_xuyong_zhou_xiaojuan_ma_lingyan_liu_zitong_zhao_xuanlin_huang_jing_fan_lijia_dong_gang_chen_liying_ma_jie_yang_longyun_chen_minghui_he_miao_li_xuehan_zhuang_kai_huang_kunlong_qiu_guangliang_yin_guangwu_guo_qiang_feng_peishan_chen_zhiyong_wu_jianyi_wu_ling_ma_jinyang_zhao_longhai_luo_ming_fu_bainan_xu_bo_chenyingrui_li_tong_tong_mingrong_wang_zhihua_liu_dongxin_lin_xiuqing_zhang_huanming_yang_jun_wang__qimin_zhan'&gt;Yongmei Song, Lin Li, Yunwei Ou, Zhibo Gao, Enmin Li, Xiangchun Li, Weimin Zhang, Jiaqian Wang, Liyan Xu,Yong Zhou, Xiaojuan Ma, Lingyan Liu, Zitong Zhao, Xuanlin Huang, Jing Fan, Lijia Dong, Gang Chen, Liying Ma, Jie Yang, Longyun Chen, Minghui He, Miao Li, Xuehan Zhuang, Kai Huang, Kunlong Qiu, Guangliang Yin, Guangwu Guo, Qiang Feng, Peishan Chen, Zhiyong Wu, Jianyi Wu, Ling Ma, Jinyang Zhao, Longhai Luo, Ming Fu, Bainan Xu, Bo Chen,Yingrui Li, Tong Tong, Mingrong Wang, Zhihua Liu, Dongxin Lin, Xiuqing Zhang, Huanming Yang, Jun Wang &amp;amp; Qimin Zhan&lt;/h5&gt;

&lt;p&gt;Oesophageal cancer is one of the most aggressive cancers and is the sixth leading cause of cancer death worldwide. Approximately 70% of global oesophageal cancer cases occur in China, with oesophageal squamous cell carcinoma (ESCC) being the histopathological form in the vast majority of cases (&amp;gt;90%). Currently, there are limited clinical approaches for the early diagnosis and treatment of ESCC, resulting in a 10% five-year survival rate for patients. However, the full repertoire of genomic events leading to the pathogenesis of ESCC remains unclear. Here we describe a comprehensive genomic analysis of 158 ESCC cases, as part of the International Cancer Genome Consortium research project. We conducted whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases, of which 53 cases, plus an additional 70 ESCC cases not used in the whole-genome and whole-exome sequencing, were subjected to array comparative genomic hybridization analysis. We identified eight significantly mutated genes, of which six are well known tumour-associated genes (TP53, RB1, CDKN2A, PIK3CA, NOTCH1, NFE2L2), and two have not previously been described in ESCC (ADAM29 and FAM135B). Notably, FAM135B is identified as a novel cancer-implicated gene as assayed for its ability to promote malignancy of ESCC cells. Additionally, MIR548K, a microRNA encoded in the amplified 11q13.3-13.4 region, is characterized as a novel oncogene, and functional assays demonstrate that MIR548K enhances malignant phenotypes of ESCC cells. Moreover, we have found that several important histone regulator genes (MLL2 (also called KMT2D), ASH1L, MLL3 (KMT2C), SETD1B, CREBBP and EP300) are frequently altered in ESCC. Pathway assessment reveals that somatic aberrations are mainly involved in the Wnt, cell cycle and Notch pathways. Genomic analyses suggest that ESCC and head and neck squamous cell carcinoma share some common pathogenic mechanisms, and ESCC development is associated with alcohol drinking. This study has explored novel biological markers and tumorigenic pathways that would greatly improve therapeutic strategies for ESCC.&lt;/p&gt;
&lt;a href='http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13176.html'&gt; read more &lt;/a&gt;</content>
 </entry>
 
 <entry>
   <title>Identification of somatic alterations in stage I lung adenocarcinomas by next‐generation sequencing</title>
   <link href="http://username.github.io//2014/01/22/Identification-of-somatic-alterations-in-stage-I-lung-adenocarcinomas-by-next-generation-sequencing"/>
   <updated>2014-01-22T00:00:00+08:00</updated>
   <id>http://username.github.io//2014/01/22/Identification-of-somatic-alterations-in-stage-I-lung-adenocarcinomas-by-next-generation-sequencing</id>
   <content type="html">&lt;p&gt;doi:10.1002/gcc.22138&lt;/p&gt;

&lt;h5 id='yuda_zhaojie_yangzhaoli_chenzhibo_gaofang_zhouxiangchun_lijiagen_lisusheng_shixiaoli_fengnan_sunran_yaochengcheng_zhousheng_changmiao_liyong_zhoulin_lixiuqing_zhangjie_he'&gt;Yuda Zhao,Jie Yang,Zhaoli Chen,Zhibo Gao,Fang Zhou,Xiangchun Li,Jiagen Li,Susheng Shi,Xiaoli Feng,Nan Sun,Ran Yao,Chengcheng Zhou,Sheng Chang,Miao Li,Yong Zhou,Lin Li,Xiuqing Zhang,Jie He&lt;/h5&gt;

&lt;p&gt;Adenocarcinoma is the most common type of lung cancer. Somatic mutations in the early stage of this disease have a tight relationship with tumor initiation and potentially activate downstream pathways that are implicated in tumor progression. In this study, we performed whole genome and exome sequencing of tumor and adjacent normal tissue from 10 patients with stage I lung adenocarcinoma. EGFR (4/10 tumors), BCHE (3/10), and TP53 (2/10) were identified recurrently with validated tumor‐specific non‐synonymous mutations; and the remaining mutations were specific to individual tumors. Computational methods were used to evaluate the potential effect of non‐synonymous mutations on protein function, and putative driver mutation in genes such as SDK1 was predicted. Cell adhesion was the most enriched biological process in gene set analysis using the DAVID database. Copy number amplification at 12q15, which includes MDM2, was identified as a recurrent somatic alteration in 4 of 10 tumors. These findings provided additional information for understanding early‐stage lung adenocarcinomas.&lt;/p&gt;
&lt;a href='http://onlinelibrary.wiley.com/enhanced/doi/10.1002/gcc.22138/'&gt; read more &lt;/a&gt;</content>
 </entry>
 
 <entry>
   <title>Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1</title>
   <link href="http://username.github.io//2013/12/10/Whole-exome-sequencing-of-insulinoma-reveals-recurrent-T372R-mutations-in-YY1"/>
   <updated>2013-12-10T00:00:00+08:00</updated>
   <id>http://username.github.io//2013/12/10/Whole-exome-sequencing-of-insulinoma-reveals-recurrent-T372R-mutations-in-YY1</id>
   <content type="html">&lt;p&gt;doi:10.1038/ncomms3810&lt;/p&gt;

&lt;p&gt;Yanan Cao,Zhibo Gao,Lin Li,Xiuli Jiang,Aijing Shan,Jie Cai,Ying Peng,Yanli Li,Xiaohua Jiang,Xuanlin Huang,Jiaqian Wang,Qing Wei,Guijun Qin,Jiajun Zhao,Xiaolong Jin,Li Liu,Yingrui Li,Weiqing Wang,Jun Wang,Guang Ning&lt;/p&gt;

&lt;p&gt;Functional pancreatic neuroendocrine tumours (PNETs) are mainly represented by insulinoma, which secrete insulin independent of glucose and cause hypoglycaemia. The major genetic alterations in sporadic insulinomas are still unknown. Here we identify recurrent somatic T372R mutations in YY1 by whole exome sequencing of 10 sporadic insulinomas. Further screening in 103 additional insulinomas reveals this hotspot mutation in 30% (34/113) of all tumours. T372R mutation alters the expression of YY1 target genes in insulinomas. Clinically, the T372R mutation is associated with the later onset of tumours. Genotyping of YY1, a target of mTOR inhibitors, may contribute to medical treatment of insulinomas. Our findings highlight the importance of YY1 in pancreatic β-cells and may provide therapeutic targets for PNETs.&lt;/p&gt;
&lt;a href='http://www.nature.com/ncomms/2013/131210/ncomms3810/full/ncomms3810.html'&gt;read more&lt;/a&gt;</content>
 </entry>
 
 <entry>
   <title>Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation</title>
   <link href="http://username.github.io//2013/10/13/Whole-genome-and-whole-exome-sequencing-of-bladder-cancer-identifies-frequent-alterations-in-genes-involved-in-sister-chromatid-cohesion-and-segregation"/>
   <updated>2013-10-13T00:00:00+08:00</updated>
   <id>http://username.github.io//2013/10/13/Whole-genome-and-whole-exome-sequencing-of-bladder-cancer-identifies-frequent-alterations-in-genes-involved-in-sister-chromatid-cohesion-and-segregation</id>
   <content type="html">&lt;p&gt;doi:10.1038/ng.2798&lt;/p&gt;

&lt;h5 id='guangwu_guoxiaojuan_sunchao_chensong_wupeide_huangzesong_limichael_deanyi_huangwenlong_jiaquan_zhouaifa_tangzuoquan_yangxianxin_lipengfei_songxiaokun_zhaorui_yeshiqiang_zhangzhao_linmingfu_qishengqing_wanliangfu_xiefan_fanmichael_l_nickersonxiangjun_zouxueda_huli_xingzhaojie_lvhongbin_meishengjie_gaochaozhao_liangzhibo_gaojingxiao_luyuan_yuchunxiao_liulin_lixiaodong_fangzhimao_jiangjie_yangcailing_lixin_zhaojing_chenfang_zhangyongqi_laizheguang_linfangjian_zhouhao_chenhsiao_chang_chanshirley_tsangdan_theodorescuyingrui_lixiuqing_zhangjian_wanghuanming_yangyaoting_guijun_wangzhiming_cai'&gt;Guangwu Guo,Xiaojuan Sun,Chao Chen,Song Wu,Peide Huang,Zesong Li,Michael Dean,Yi Huang,Wenlong Jia,Quan Zhou,Aifa Tang,Zuoquan Yang,Xianxin Li,Pengfei Song,Xiaokun Zhao,Rui Ye,Shiqiang Zhang,Zhao Lin,Mingfu Qi,Shengqing Wan,Liangfu Xie,Fan Fan,Michael L Nickerson,Xiangjun Zou,Xueda Hu,Li Xing,Zhaojie Lv,Hongbin Mei,Shengjie Gao,Chaozhao Liang,Zhibo Gao,Jingxiao Lu,Yuan Yu,Chunxiao Liu,Lin Li,Xiaodong Fang,Zhimao Jiang,Jie Yang,Cailing Li,Xin Zhao,Jing Chen,Fang Zhang,Yongqi Lai,Zheguang Lin,Fangjian Zhou,Hao Chen,Hsiao Chang Chan,Shirley Tsang,Dan Theodorescu,Yingrui Li,Xiuqing Zhang,Jian Wang,Huanming Yang,Yaoting Gui,Jun Wang,Zhiming Cai&lt;/h5&gt;

&lt;p&gt;Bladder cancer is one of the most common cancers worldwide, with transitional cell carcinoma (TCC) being the predominant form. Here we report a genomic analysis of TCC by both whole-genome and whole-exome sequencing of 99 individuals with TCC. Beyond confirming recurrent mutations in genes previously identified as being mutated in TCC, we identified additional altered genes and pathways that were implicated in TCC. Notably, we discovered frequent alterations in STAG2 and ESPL1, two genes involved in the sister chromatid cohesion and segregation (SCCS) process. Furthermore, we also detected a recurrent fusion involving FGFR3 and TACC3, another component of SCCS, by transcriptome sequencing of 42 DNA-sequenced tumors. Overall, 32 of the 99 tumors (32%) harbored genetic alterations in the SCCS process. Our analysis provides evidence that genetic alterations affecting the SCCS process may be involved in bladder tumorigenesis and identifies a new therapeutic possibility for bladder cancer.&lt;/p&gt;
&lt;a href='http://www.nature.com/ng/journal/v45/n12/full/ng.2798.html'&gt; read more &lt;/a&gt;</content>
 </entry>
 
 <entry>
   <title>Whole genome sequencing identifies recurrent mutations in hepatocellular carcinoma</title>
   <link href="http://username.github.io//2013/06/17/Whole-genome-sequencing-identifies-recurrent-mutations-in-hepatocellular-carcinoma"/>
   <updated>2013-06-17T00:00:00+08:00</updated>
   <id>http://username.github.io//2013/06/17/Whole-genome-sequencing-identifies-recurrent-mutations-in-hepatocellular-carcinoma</id>
   <content type="html">&lt;p&gt;doi: 10.1101/gr.154492.113&lt;/p&gt;

&lt;h5 id='zhengyan_kanhancheng_zhengxiao_liushuyu_lithomas_barberzhuolin_gonghuan_gaoke_haomelinda_d_willardjiangchun_xurobert_hauptscheinpaul_a_rejtojulio_fernandezguan_wangqinghui_zhangbo_wangronghua_chenjian_wangnikki_p_leewei_zhouzhao_linzhiyu_pengkang_yishengpei_chenlin_lixiaomei_fanjie_yangrui_yejia_jukai_wangheather_estrellashibing_dengping_weiming_qiuisabella_h_wulurjiangang_liumariam_e_ehsanichunsheng_zhangandrey_lobodawing_kin_sungamit_aggarwalronnie_t_poonsheung_tat_fanjames_hardwickjun_wangchristoph_reinhardhongyue_daiyingrui_lijohn_m_lukmao_mao'&gt;Zhengyan Kan,Hancheng Zheng,Xiao Liu,Shuyu Li,Thomas Barber,Zhuolin Gong,Huan Gao,Ke Hao,Melinda D Willard,Jiangchun Xu,Robert Hauptschein,Paul A Rejto,Julio Fernandez,Guan Wang,Qinghui Zhang,Bo Wang,Ronghua Chen,Jian Wang,Nikki P Lee,Wei Zhou,Zhao Lin,Zhiyu Peng,Kang Yi,Shengpei Chen,Lin Li,Xiaomei Fan,Jie Yang,Rui Ye,Jia Ju,Kai Wang,Heather Estrella,Shibing Deng,Ping Wei,Ming Qiu,Isabella H Wulur,Jiangang Liu,Mariam E Ehsani,Chunsheng Zhang,Andrey Loboda,Wing Kin Sung,Amit Aggarwal,Ronnie T Poon,Sheung Tat Fan,James Hardwick,Jun Wang,Christoph Reinhard,Hongyue Dai,Yingrui Li,John M Luk,Mao Mao&lt;/h5&gt;

&lt;p&gt;Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown. Here we report findings from a whole genome sequencing (WGS) study of 88 matched HCC tumor/normal pairs, 81 of which are HBV positive, seeking to identify genetically altered genes and pathways implicated in HBV-associated HCC. We find beta catenin to be the most frequently mutated oncogene (15.9%) and TP53 the most frequently mutated tumor suppressor (35.2%). The Wnt/beta catenin and JAK/STAT pathways, altered in 62.5% and 45.5% of cases respectively, are likely to act as two major oncogenic drivers in HCC. This study also identifies several prevalent and potentially actionable mutations including activating mutations of Janus Kinase 1 (JAK1) in 9.1% of patients and provides a path towards therapeutic intervention of the disease.&lt;/p&gt;
&lt;a href='http://genome.cshlp.org/content/early/2013/06/19/gr.154492.113'&gt;read more&lt;/a&gt;</content>
 </entry>
 
 
</feed>